How attitudes toward artificial intelligence relate to anxiety and quality of life in women receiving infertility treatment
The Relationship Between Quality of Life, Anxiety Levels, and Attitudes Toward Artificial Intelligence Among Women Undergoing Infertility Treatment
Acibadem University · NCT07308561
This study will test whether women's attitudes toward artificial intelligence are linked to their anxiety and quality of life while undergoing infertility treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 191 (estimated) |
| Ages | 18 Years to 45 Years |
| Sex | Female |
| Sponsor | Acibadem University (other) |
| Locations | 1 site (Istanbul, Ataşehir) |
| Trial ID | NCT07308561 on ClinicalTrials.gov |
What this trial studies
This is an observational, questionnaire-based study of women aged 18–45 receiving infertility treatments (IUI, IVF, ICSI) at Acıbadem Health Group in Istanbul. Participants who speak Turkish and do not have diagnosed psychological disorders will complete validated measures of anxiety, quality of life, and attitudes toward AI. Researchers will analyze associations between AI attitudes and psychosocial outcomes and explore whether these relationships differ by treatment modality or demographic factors. The study aims to identify patterns that could inform communication and support strategies in fertility care.
Who should consider this trial
Good fit: Women aged 18–45 with primary or secondary infertility who are currently receiving infertility treatment (IUI, IVF, or ICSI) at Acıbadem and who can read and speak Turkish are ideal candidates.
Not a fit: Women who are not undergoing infertility treatment, those with diagnosed psychiatric disorders, non-Turkish speakers, or those unable to attend the Istanbul site are unlikely to benefit from participation.
Why it matters
Potential benefit: If successful, the findings could help tailor patient communication and support to reduce anxiety and improve quality of life while increasing appropriate acceptance of AI tools in infertility care.
How similar studies have performed: Previous research shows AI can support clinical decision-making in reproductive medicine and that anxiety affects quality of life, but direct study of how attitudes toward AI influence psychosocial outcomes in infertility is relatively limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women aged 18-45 years diagnosed with infertility (primary or secondary infertility). * Women undergoing infertility treatment and those who have experienced various treatment modalities (IUI, IVF, ICSI). * Women who voluntarily agree to participate in the study. * Women who are able to understand and speak Turkish. Exclusion Criteria: * Women with diagnosed psychological disorders (e.g., clinical depression, anxiety disorders). * Women who are not undergoing infertility treatment.
Where this trial is running
Istanbul, Ataşehir
- Acıbadem Health Group — Istanbul, Ataşehir, Turkey (Türkiye) (RECRUITING)
Study contacts
- Study coordinator: Güzin Ünlü Suvari, M.Sc.
- Email: guzin.unlu@acibadem.edu.tr
- Phone: +902165004429
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Infertility, Female, Artificial Intelligence, Quality of Life, Anxiety